- Dow Jones Industrial Average rose 177.44 points, or 0.69%, to 26,067.62.
- S&P 500 gained 24.72 points, or 0.79%, to 3,170.04.
- The Nasdaq Composite added 148.61 points, or 1.44%, to 10,492.50.
US stocks rose on Wednesday, amid a general absence of market-moving news, were making a comeback, denying the bears and resulted in the Nasdaq hitting another record closing high.
Despite the potential consequences of these spikes in new coronavirus case, patient investors continue to buy into the central bank and fiscal stimulus efforts and global economic recovery.
US Fauci said Phase 3 vaccine trials may begin at end July, and that he is cautiously optimistic for a vaccine by year-end, and that is enough for the market to keep on the bid.
Unofficially, the Dow Jones Industrial Average rose 177.44 points, or 0.69%, to 26,067.62, the S&P 500 gained 24.72 points, or 0.79%, to 3,170.04 and the Nasdaq Composite added 148.61 points, or 1.44%, to 10,492.50.
US COVID-19 surpassed 3 million
US cases of COVID-19 surpassed 3 million overnight, affecting nearly one of every 100 Americans. California, Hawaii, Idaho, Missouri, Montana, Oklahoma and Texas broke their previous daily record highs for new infections.
Fed’s Bostic reiterated that the infections spikes are clouding the reopening outlook, but broad shut down isn’t expected.
Meanwhile, US-China tensions continue to bubble. US Kudlow said the US has issues with China but a trade deal is not dead.
|Today last price||25876|
|Today Daily Change||-246.00|
|Today Daily Change %||-0.94|
|Today daily open||26122|
|Previous Daily High||26182|
|Previous Daily Low||25980|
|Previous Weekly High||26198|
|Previous Weekly Low||24974|
|Previous Monthly High||27628|
|Previous Monthly Low||24562|
|Daily Fibonacci 38.2%||26057.16|
|Daily Fibonacci 61.8%||26104.84|
|Daily Pivot Point S1||26007.33|
|Daily Pivot Point S2||25892.67|
|Daily Pivot Point S3||25805.33|
|Daily Pivot Point R1||26209.33|
|Daily Pivot Point R2||26296.67|
|Daily Pivot Point R3||26411.33|
Information on these pages contains forward-looking statements that involve risks and uncertainties. Markets and instruments profiled on this page are for informational purposes only and should not in any way come across as a recommendation to buy or sell in these assets. You should do your own thorough research before making any investment decisions. FXStreet does not in any way guarantee that this information is free from mistakes, errors, or material misstatements. It also does not guarantee that this information is of a timely nature. Investing in Open Markets involves a great deal of risk, including the loss of all or a portion of your investment, as well as emotional distress. All risks, losses and costs associated with investing, including total loss of principal, are your responsibility. The views and opinions expressed in this article are those of the authors and do not necessarily reflect the official policy or position of FXStreet nor its advertisers.